partnering

News

Pathos AI signs two cancer deals with Alphamab and AZ

Pathos AI has grown its oncology pipeline by licensing a bispecific ADC from Alphamab for $125m and partnering a breast cancer drug from AstraZeneca.

News

AI specialist Chai Discovery raises $400m

Fresh from an alliance with Novartis, Chai Discovery has raised $400 million in third-round funding for its AI-based molecular design platform.

News

GSK ends dementia alliance with Alector after setbacks

GSK's alliance with Alector to develop two drug candidates for dementia has been terminated in the wake of disappointing clinical trial results.

News

Roche looks to Astex in $515m breast cancer deal

Roche's Genentech unit has forged an alliance with Astex, worth up to $515m, to partner on a fragment-based drug discovery programme in breast cancer.

News

Insilico and SK Bio forge $2.5bn AI neuroimmunity alliance

Insilico Medicine has teamed up with SK Biopharmaceuticals on a wide-ranging, $2.5bn partnership to use AI to find neuroimmune drug candidates.

News

MSD steps out with Protillion in $510m+ AI shindig

MSD has teamed up with Protillion Bio in a deal worth more than $510m, focusing on using the AI start-up's lab-in-the-loop platform for drug discovery

Pathos AI signs two cancer deals with Alphamab and AZ

AI specialist Chai Discovery raises $400m

GSK ends dementia alliance with Alector after setbacks

Roche looks to Astex in $515m breast cancer deal

Insilico and SK Bio forge $2.5bn AI neuroimmunity alliance

MSD steps out with Protillion in $510m+ AI shindig

TransThera's resistant biliary cancer drug cleared in China

Discover a new era of healthcare panel engagement: Grounded ...

partnering

Editor's Picks